Blood Transfusion Refusal Poses No Risk in Cardiac Patients
The study suggests that blood transfusions in and of themselves carry under-recognized risks that offset risks from refusing blood transfusions, says Pattakos, who now is a general surgery resident at Georgetown University Hospital in Washington, D.C.
He cautions that the results should not be overinterpreted, because the topic requires much more research for validation.
He emphasizes, however, that surgeons should give the idea of transfusion a lot more thought for each patient, rather than acting with "a knee-jerk reaction when a particular (hemoglobin or hematocrit) level is reached."
For Jehovah's Witness patients undergoing cardiac surgery, common strategies include initiating doses of the drug erythropoietin and iron and B-complex vitamins, hemoconcentation and minimal crystalloid use, intraoperative use of antifibrinolytics and cell saver and smaller cardiopulmonary bypass circuits, and postoperative liberal use of additional operations for bleeding, the researchers wrote.
- Healthcare Leaders Seek Strategic Sweet Spot
- 3 Reasons Wellness Programs Fail
- CMS Issues Health Insurance Exchange Proposed Rules
- Patients Shoulder Nearly 25% of Medical Bills
- ACOs Widespread, Yet Challenged
- MGMA: Physician Compensation Increasingly Based on Quality Measures
- 6 CNO-to-CEO Strategies
- Healthcare Costs 'An Abomination' Says Senate Finance Committee Chair
- Healthcare Consolidation: M&A Not the Only Way
- HFMA: Patient Financial Interaction Guidelines Sharpened